UBS Keeps Underweight Stance on Chinese Equitiesby Mark Eisenberg 09.08.2024UBS reports foreign investors maintain caution, holding underweight positions in Chinese equities amid market uncertainties.
China’s Inflation Surprises in July Amid Rate Cutsby Mark Eisenberg 09.08.2024China's CPI inflation exceeded expectations in July as PPI continued shrinking. Economic challenges persist.
Exploring China’s XR Ecosystem: A Journey Through Key Citiesby Lilu Anderson 07.08.2024Join us as we explore China's XR ecosystem from August 29 to September 23, visiting Guangzhou, Shenzhen, Hangzhou, Qingdao, and ...
Asian Stocks Rise, Nikkei Extends Rebound on BOJ Commentsby Mark Eisenberg 07.08.2024Asian stocks recover from losses, led by Nikkei's surge following BOJ rate comments. Gains limited due to global economic concerns.
Chinese Hackers Intensify Attacks on Taiwanese Targetsby Lilu Anderson 24.06.2024Chinese Hackers Ramp Up Attacks on Taiwanese Entities, Recorded Future Reports. Focus on Govt, Education, Tech Sectors Amid Rising Tensions.
UBS Neutral on EM Stocks; Favors Tech in China, S. Koreaby Mark Eisenberg 24.06.2024UBS neutral on EM stocks due to political risks but favors AI-related tech stocks in Taiwan and South Korea, and ...
China Urges EU to Drop EV Tariffs Before July 4 Talksby Mark Eisenberg 24.06.2024China urges the EU to lift tariffs on Chinese EVs by July 4 amid renewed talks, aiming to avoid trade ...
Asian Stocks Slide on China-EU Trade Concerns, Inflation Eyesby Mark Eisenberg 24.06.2024Asian stocks drop amid China-EU trade war fears and U.S. inflation concerns. Chinese, Australian, and South Korean markets decline; Japan ...
QuantaSing Group vs. 17 Education & Technology: Financial Face-offby Lilu Anderson 23.06.2024Compare QuantaSing Group (QSG) and 17 Education & Technology Group (YQ) in terms of risk, analyst ratings, ownership, profitability, and ...
U.S. Crackdown on Chinese Biotech Could Harm Patientsby Lilu Anderson 22.06.2024America's crackdown on Chinese biotech could lead to drug shortages and higher costs, impacting patients without delivering promised security benefits.